OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each bottle)
Magnesium Aluminosilicate 900 mg
Magnesium Hydroxide 250 mg
Active ingredients (in each bottle)
Magnesium Aluminosilicate 900 mg
Magnesium Hydroxide 250 mg
Purpose
Magnesium Aluminosilicate Antacid
Magnesium Hydroxide Antacid
Uses relieves these symptoms:
■ heartburn ■ sour stomach ■ acid indigestion
Warnings
Do not use this product if you are taking a prescription antibiotic drug containing any
form of tetracycline.
Ask a doctor or pharmacist before use if you are presently taking a prescription drug.
Antacids may interact with certain prescription drugs.
When using this product
■ do not take more than 2 bottles (adults and children 12 years and over) in a 24-hour
period or use the maximum dosage of this product for more than 2 weeks, except under
the advice and supervision of a physician.
■ may have a laxative effect.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Directions
■ adults and children 12 years and over: Take 1 bottle (30mL) at a time 2 times daily,
between meals, or as directed by a doctor.
■ children under 12 years: Ask a doctor.
■ shake well before use.
Other information
■ each bottle contains: sodium 15 mg, magnesium 165 mg
Inactive ingredients alcohol, butylparaben, citric acid, flavors (cinnamon oil, fluid
extract of ginger root, spearmint oil), hydroxypropylstarch, PEG-60 hydrogenated castor
oil, propylparaben, sodium benzoate, sodium citrate, sorbitol, water.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1246297 | aluminum magnesium silicate 900 MG / magnesium hydroxide 250 MG in 30 mL Oral Solution | PSN | 7 |
| 1246303 | Inon Ace 900 MG / 250 MG in 30 mL Oral Solution | PSN | 7 |
| 1246303 | aluminum magnesium silicate 30 MG/ML / magnesium hydroxide 8.33 MG/ML Oral Solution [Inon Ace Solution] | SBD | 7 |
| 1246297 | aluminum magnesium silicate 30 MG/ML / magnesium hydroxide 8.33 MG/ML Oral Solution | SCD | 7 |
| 1246303 | Inon Ace Solution (aluminum magnesium silicate 30 MG/ML / magnesium hydroxide 8.33 MG/ML) Oral Solution | SY | 7 |
| 1246303 | Inon Ace Solution (aluminum magnesium silicate 900 MG / magnesium hydroxide 250 MG) per 30 ML Oral Solution | SY | 7 |
| Class | Version | Type | Effective |
|---|---|---|---|
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49873-403-01 | Inon Ace | 2 in 1 CARTON | SOLUTION | 2 | 7 | |
| 49873-403-01 | Inon Ace | 30 mL in 1 BOTTLE | SOLUTION | 30 | 7 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MAGNESIUM HYDROXIDE | ACTIVE INGREDIENT | NBZ3QY004S | 3 | |
| SILODRATE | ACTIVE INGREDIENT | 9T3UU8T0QK | 3 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 3 | |
| SILODRATE | ACTIVE MOIETY | 9T3UU8T0QK | 3 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 3 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 3 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 3 | |
| HYDROXYPROPYL CORN STARCH (5% SUBSTITUTION BY WEIGHT) | INACTIVE INGREDIENT | 9M44R3409A | 3 | |
| POLYOXYL 60 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 02NG325BQG | 3 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 3 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 3 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | 3 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49873-403 | 49873-403-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| BUTYLPARABEN | 3QPI1U3FV8 | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| HYDROXYPROPYL CORN STARCH (5% SUBSTITUTION BY WEIGHT) | 9M44R3409A | IACT |
| POLYOXYL 60 HYDROGENATED CASTOR OIL | 02NG325BQG | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SORBITOL | 506T60A25R | IACT |
| WATER | 059QF0KO0R | IACT |
| SILODRATE | 9T3UU8T0QK | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | GEL / TOPICAL | 352 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | INJECTION / INTRAVENOUS | 20 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SOLUTION / ORAL | 6 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SOLUTION / ORAL | 6 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | GEL / TOPICAL | 352 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | INJECTION / INTRAVENOUS | 20 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | CREAM / TOPICAL | 1.9 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| POLYOXYL 60 HYDROGENATED CASTOR OIL | PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | CREAM / TOPICAL | 1.9 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Inon Ace | MAGNESIUM ALUMINOSILICATE, MAGNESIUM HYDROXIDE | Sato Pharmaceutical Co., Ltd. | a6e4475c-dfac-493c-b98a-21473e3b59d5 | 2023-12-06 | Warnings | 49873-403-01 49873-403 49873040301 0bde7bd2-8a69-57b4-e063-6394a90a00d2 a6e4475c-dfac-493c-b98a-21473e3b59d5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.